Zurcher Kantonalbank Zurich Cantonalbank Has $170,000 Stock Holdings in Stem, Inc. (NYSE:STEM)

Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Stem, Inc. (NYSE:STEM) by 24.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 43,693 shares of the company’s stock after purchasing an additional 8,506 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Stem were worth $170,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Quadrature Capital Ltd lifted its holdings in shares of Stem by 289.5% during the 3rd quarter. Quadrature Capital Ltd now owns 51,895 shares of the company’s stock valued at $220,000 after buying an additional 38,570 shares during the last quarter. Lido Advisors LLC acquired a new stake in Stem in the third quarter valued at approximately $4,561,000. DNB Asset Management AS grew its position in Stem by 63.7% in the fourth quarter. DNB Asset Management AS now owns 126,568 shares of the company’s stock worth $491,000 after acquiring an additional 49,256 shares in the last quarter. Deutsche Bank AG increased its stake in shares of Stem by 3.8% during the 3rd quarter. Deutsche Bank AG now owns 605,722 shares of the company’s stock worth $2,568,000 after purchasing an additional 22,222 shares during the last quarter. Finally, SG Americas Securities LLC bought a new position in shares of Stem during the 4th quarter valued at $209,000. Hedge funds and other institutional investors own 61.63% of the company’s stock.

Insider Buying and Selling

In other news, CEO John Eugene Carrington sold 194,171 shares of the stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $1.85, for a total value of $359,216.35. Following the completion of the transaction, the chief executive officer now directly owns 506,585 shares of the company’s stock, valued at approximately $937,182.25. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other Stem news, CRO Alan Russo sold 14,390 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $3.17, for a total transaction of $45,616.30. Following the sale, the executive now directly owns 158,204 shares of the company’s stock, valued at $501,506.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO John Eugene Carrington sold 194,171 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $1.85, for a total transaction of $359,216.35. Following the sale, the chief executive officer now directly owns 506,585 shares of the company’s stock, valued at approximately $937,182.25. The disclosure for this sale can be found here. Over the last quarter, insiders acquired 130,418 shares of company stock valued at $238,045 and sold 772,268 shares valued at $1,650,229. Company insiders own 10.17% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on STEM shares. UBS Group lowered their target price on shares of Stem from $5.00 to $2.50 and set a “buy” rating on the stock in a research report on Wednesday. BMO Capital Markets reduced their target price on Stem from $2.50 to $1.85 and set a “market perform” rating for the company in a report on Friday, May 3rd. Susquehanna reduced their price objective on shares of Stem from $5.50 to $4.00 and set a “positive” rating for the company in a research note on Thursday, February 29th. The Goldman Sachs Group dropped their target price on shares of Stem from $2.50 to $2.00 and set a “neutral” rating on the stock in a report on Monday. Finally, TD Cowen decreased their price target on shares of Stem from $7.00 to $5.00 and set an “outperform” rating for the company in a report on Thursday, February 29th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, Stem currently has an average rating of “Hold” and an average price target of $4.77.

Stem Price Performance

Shares of NYSE:STEM opened at $1.37 on Thursday. The business’s 50 day moving average is $1.93 and its 200-day moving average is $2.79. The company has a current ratio of 1.88, a quick ratio of 1.78 and a debt-to-equity ratio of 1.23. The firm has a market capitalization of $215.36 million, a PE ratio of -0.94 and a beta of 1.91. Stem, Inc. has a 1-year low of $1.27 and a 1-year high of $7.79.

Stem (NYSE:STEM) last announced its quarterly earnings results on Thursday, May 2nd. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.25). The business had revenue of $25.50 million during the quarter, compared to the consensus estimate of $66.67 million. Stem had a negative net margin of 40.03% and a negative return on equity of 34.37%. The company’s quarterly revenue was down 61.9% compared to the same quarter last year. During the same period last year, the firm earned ($0.29) EPS. Sell-side analysts predict that Stem, Inc. will post -0.51 earnings per share for the current year.

Stem Profile

Stem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems.